Literature DB >> 3992076

A Wilcoxon-type test for trend.

J Cuzick.   

Abstract

An extension of the Wilcoxon rank-sum test is developed to handle the situation in which a variable is measured for individuals in three or more (ordered) groups and a non-parametric test for trend across these groups is desired. The uses of the test are illustrated by two examples from cancer research.

Entities:  

Mesh：

Year:  1985        PMID： 3992076     DOI： 10.1002/sim.4780040112

Source DB:  PubMed          Journal:  Stat Med        ISSN： 0277-6715            Impact factor:   2.373


  520 in total

1.  Mineral fibre analysis and routes of exposure to asbestos in the development of mesothelioma in an English region.

Authors:  D Howel; A Gibbs; L Arblaster; L Swinburne; M Schweiger; E Renvoize; P Hatton; F Pooley
Journal:  Occup Environ Med       Date:  1999-01       Impact factor: 4.402

2.  Factors associated with serum polybrominated diphenyl ether (PBDE) levels among school-age children in the CHAMACOS cohort.

Authors:  Asa Bradman; Rosemary Castorina; Andreas Sjödin; Laura Fenster; Richard S Jones; Kim G Harley; Jonathan Chevrier; Nina T Holland; Brenda Eskenazi
Journal:  Environ Sci Technol       Date:  2012-06-12       Impact factor: 9.028

3.  Do physician organizations located in lower socioeconomic status areas score lower on pay-for-performance measures?

Authors:  Alyna T Chien; Kristen Wroblewski; Cheryl Damberg; Thomas R Williams; Dolores Yanagihara; Yelena Yakunina; Lawrence P Casalino
Journal:  J Gen Intern Med       Date:  2011-12-13       Impact factor: 5.128

4.  The prognostic value of myocardial deformational patterns on all-cause mortality is modified by ischemic cardiomyopathy in patients with heart failure.

Authors:  Philip Brainin; Anna Engell Holm; Morten Sengeløv; Peter Godsk Jørgensen; Niels Eske Bruun; Morten Schou; Sune Pedersen; Thomas Fritz-Hansen; Tor Biering-Sørensen
Journal:  Int J Cardiovasc Imaging       Date:  2021-05-24       Impact factor: 2.357

5.  Changes in Quality of Life in Older Hemodialysis Patients: A Cohort Study on Dialysis Outcomes and Practice Patterns.

Authors:  Ayumi Ishiwatari; Shungo Yamamoto; Shingo Fukuma; Takeshi Hasegawa; Sachiko Wakai; Masaomi Nangaku
Journal:  Am J Nephrol       Date:  2020-07-31       Impact factor: 3.754

6.  Association Between Patient Age and Lymph Node Positivity in Thin Melanoma.

Authors:  Andrew J Sinnamon; Madalyn G Neuwirth; Pratyusha Yalamanchi; Phyllis Gimotty; David E Elder; Xiaowei Xu; Rachel R Kelz; Robert E Roses; Emily Y Chu; Michael E Ming; Douglas L Fraker; Giorgos C Karakousis
Journal:  JAMA Dermatol       Date:  2017-09-01       Impact factor: 10.282

7.  Numeracy and Interpretation of Prognostic Estimates in Intracerebral Hemorrhage Among Surrogate Decision Makers in the Neurologic ICU.

Authors:  Nikita Leiter; Melissa Motta; Robert M Reed; Temitope Adeyeye; Debra L Wiegand; Nirav G Shah; Avelino C Verceles; Giora Netzer
Journal:  Crit Care Med       Date:  2018-02       Impact factor: 7.598

8.  Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus.

Authors:  K O Kong; A W Tan; B Y H Thong; T Y Lian; Y K Cheng; C L Teh; E T Koh; H H Chng; W G Law; T C Lau; K P Leong; B P Leung; H S Howe
Journal:  Clin Exp Immunol       Date:  2009-01-23       Impact factor: 4.330

9.  Severe sepsis cohorts derived from claims-based strategies appear to be biased toward a more severely ill patient population.

Authors:  Stacey-Ann Whittaker; Mark E Mikkelsen; David F Gaieski; Sherine Koshy; Craig Kean; Barry D Fuchs
Journal:  Crit Care Med       Date:  2013-04       Impact factor: 7.598

10.  NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.

Authors:  Clint S Schmidt; C Jo White; Ashraf S Ibrahim; Scott G Filler; Yue Fu; Michael R Yeaman; John E Edwards; John P Hennessey
Journal:  Vaccine       Date:  2012-10-22       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.